.jpeg)
Biocon acquires US-based Eywa Pharma for $7.7 million
A unit of biotechnology major Biocon has acquired the oral solid dosage manufacturing factory of Eywa Pharma Inc. in the US for USD 7.7 million. Let us tell you that Iva Pharma Inc. has the capacity to expand the capacity up to 2 billion tablets/capsules every year. Know how the stock of the company was yesterday. Read what is the complete news.
B
Business
NEWS CARD
“Biocon acquires US-based Eywa Pharma for $7.7 million”
Read more onsangritoday.com
2 Sep 2023
A unit of biotechnology major Biocon has acquired Eywa Pharma Inc.'s oral solid dosage manufacturing factory in the US for USD 7.7 million (over Rs 63 crore).
In a statement, the Bengaluru-based Biocon company said Biocon Generics Inc. has acquired the Cranbury, Iowa plant with effect from September 1, 2023. As part of the acquisition, Iwa's existing workforce will now work for Biocon Generics Inc.
Let us tell you that Iva Pharma Inc. can increase its production capacity to 2 billion tablets/capsules per year.
